• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质代谢与免疫功能的关联:慢性呼吸道疾病的新见解

Linking Lipid Metabolism and Immune Function: New Insights into Chronic Respiratory Diseases.

作者信息

Kotlyarov Stanislav

机构信息

Department of Nursing, Ryazan State Medical University, 390026 Ryazan, Russia.

出版信息

Pathophysiology. 2025 Jun 6;32(2):26. doi: 10.3390/pathophysiology32020026.

DOI:10.3390/pathophysiology32020026
PMID:40559469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12195652/
Abstract

Lipids play important roles in maintaining pulmonary structure, performing physiological functions and controlling the immune status of the lung. There is increasing evidence that lipid metabolism and immune activity are closely linked and that dysfunction in lipid metabolism contributes to the development and progression of chronic respiratory diseases such as COPD and asthma. These diseases are characterized by metabolic and immune dysregulation, with lipid mediators playing a key role in both the development and resolution of inflammation. In this regard, lipid metabolic pathways are attracting increasing attention as promising targets for biomarker detection and therapeutic intervention.

摘要

脂质在维持肺部结构、执行生理功能以及控制肺部免疫状态方面发挥着重要作用。越来越多的证据表明,脂质代谢与免疫活性密切相关,脂质代谢功能障碍会导致慢性呼吸道疾病(如慢性阻塞性肺疾病和哮喘)的发生和发展。这些疾病的特征是代谢和免疫失调,脂质介质在炎症的发生和消退中均起关键作用。在这方面,脂质代谢途径作为生物标志物检测和治疗干预的有前景的靶点正受到越来越多的关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f586/12195652/d2be9c11aebe/pathophysiology-32-00026-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f586/12195652/ed0efd244f5f/pathophysiology-32-00026-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f586/12195652/d2be9c11aebe/pathophysiology-32-00026-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f586/12195652/ed0efd244f5f/pathophysiology-32-00026-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f586/12195652/d2be9c11aebe/pathophysiology-32-00026-g002.jpg

相似文献

1
Linking Lipid Metabolism and Immune Function: New Insights into Chronic Respiratory Diseases.脂质代谢与免疫功能的关联:慢性呼吸道疾病的新见解
Pathophysiology. 2025 Jun 6;32(2):26. doi: 10.3390/pathophysiology32020026.
2
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Weight loss interventions for chronic asthma.慢性哮喘的体重减轻干预措施。
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD009339. doi: 10.1002/14651858.CD009339.pub2.
5
Aural toilet (ear cleaning) for chronic suppurative otitis media.慢性化脓性中耳炎的耳道清理(耳部清洁)
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
6
p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics.p38 MAPK 信号通路在慢性阻塞性肺疾病发病机制及抑制剂治疗中的作用
Cell Commun Signal. 2023 Nov 2;21(1):314. doi: 10.1186/s12964-023-01337-4.
7
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果:面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.
8
Psychological interventions for adults who have sexually offended or are at risk of offending.针对有性犯罪行为或有性犯罪风险的成年人的心理干预措施。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD007507. doi: 10.1002/14651858.CD007507.pub2.
9
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施(包括针对病情加重的行动计划)与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.
10
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.

引用本文的文献

1
Associations between serum lipid profiles and the incidence of chronic obstructive pulmonary disease in the UK Biobank.英国生物银行中血清脂质谱与慢性阻塞性肺疾病发病率之间的关联。
J Health Popul Nutr. 2025 Aug 6;44(1):281. doi: 10.1186/s41043-025-01026-7.

本文引用的文献

1
PLK1 Mediates the Proliferation and Contraction of Airway Smooth Muscle Cells and Has a Role in T2-High Asthma with Neutrophilic Inflammation Model.PLK1介导气道平滑肌细胞的增殖和收缩,并在伴有嗜中性粒细胞炎症模型的T2高哮喘中发挥作用。
J Inflamm Res. 2025 Mar 25;18:4381-4394. doi: 10.2147/JIR.S501645. eCollection 2025.
2
Dysregulation of lipid mediators in patients with frequent exacerbations of COPD.慢性阻塞性肺疾病频繁急性加重患者脂质介质的失调
ERJ Open Res. 2025 Mar 24;11(2). doi: 10.1183/23120541.00950-2023. eCollection 2025 Mar.
3
LXA4 alleviates inflammation and ferroptosis in cigarette smoke induced chronic obstructive pulmonary disease via the ALX/FPR2 receptor.
脂氧素A4通过ALX/FPR2受体减轻香烟烟雾诱导的慢性阻塞性肺疾病中的炎症和铁死亡。
Int Immunopharmacol. 2025 Apr 4;151:114322. doi: 10.1016/j.intimp.2025.114322. Epub 2025 Feb 24.
4
Lipid-lowering drug targets associated with risk of respiratory disease: a Mendelian randomization study.与呼吸系统疾病风险相关的降脂药物靶点:一项孟德尔随机化研究
BMC Pulm Med. 2025 Feb 11;25(1):71. doi: 10.1186/s12890-025-03527-x.
5
Causal Relationships Between Blood Lipid Levels and Chronic Obstructive Pulmonary Disease: A Mendelian Randomization Analysis.血脂水平与慢性阻塞性肺疾病之间的因果关系:一项孟德尔随机化分析
Int J Chron Obstruct Pulmon Dis. 2025 Jan 8;20:83-93. doi: 10.2147/COPD.S476833. eCollection 2025.
6
Global, regional, and national burden of chronic obstructive pulmonary disease and its attributable risk factors from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021.1990年至2021年慢性阻塞性肺疾病及其可归因风险因素的全球、区域和国家负担:全球疾病负担研究2021的分析
Respir Res. 2025 Jan 2;26(1):2. doi: 10.1186/s12931-024-03051-2.
7
Serum cholesterol levels predict the survival in patients with idiopathic pulmonary fibrosis: A long-term follow up study.血清胆固醇水平可预测特发性肺纤维化患者的生存率:一项长期随访研究。
Respir Med. 2025 Feb;237:107937. doi: 10.1016/j.rmed.2024.107937. Epub 2024 Dec 31.
8
Lipoprotein-associated phospholipase A2 and its possible association with COPD development: a case-control study.脂蛋白相关磷脂酶 A2 及其与 COPD 发展的可能关联:一项病例对照研究。
BMC Pulm Med. 2024 Nov 13;24(1):565. doi: 10.1186/s12890-024-03335-9.
9
20-year trends in excess costs of COPD.慢性阻塞性肺疾病(COPD)超额成本的20年趋势。
Eur Respir J. 2025 Jan 30;65(1). doi: 10.1183/13993003.00516-2024. Print 2025 Jan.
10
Cysteinyl Leukotrienes in Allergic Inflammation.过敏炎症中的半胱氨酰白三烯
Annu Rev Pathol. 2025 Jan;20(1):115-141. doi: 10.1146/annurev-pathmechdis-111523-023509. Epub 2025 Jan 2.